Sandwich hybridization assays using very short capture probes noncovalently bound to a hydrophobic support

• US 5,695,926 A
• Filed: 06/07/1994
• Issued: 12/09/1997
• Est. Priority Date: 06/11/1990
• Status: Expired due to Term

• Current Assignee: Bio Merieux
• Original Assignee: Bio Merieux
• Inventors: Allibert, Patrice, Mandrand, Bernard, Mabilat, Claude, Cros, Philippe, Mallet, Fran.cedilla.ois
• Primary Examiner(s): Horlick, Kenneth R.
• Application Number:
  US08/255,892
• Time in Patent Office: 1,281 Days
• Field of Search: 435/6, 435/5, 935/78, 436/94
• US Class Current: 435/5
• CPC Class Codes: C12Q 1/6813 Hybridisation assays
• CPC Class Codes: C12Q 1/6834 Enzymatic or biochemical coupling of nucleic acids to a solid phase

Abstract

A procedure for detecting single-stranded nucleotide sequences in a sample is disclosed wherein a passively fixed capture probe is used in concert with a non-radioactively labelled detection probe in a sandwich hybridization technique.

Claims

1. Procedure for the detection of a single-stranded polynucleotide target sequence in a sample, comprising the steps consisting of:

a) incubating the sample;

i) with a capture probe adsorbed to a hydrophobic solid support, wherein said capture probe is an oligonucleotide having from 11 to 19 nucleotides and said capture probe is not derivatized with a moiety to facilitate adsorption, and

ii) with a detection probe labelled with a non-radioactive marker, said capture probe and said detection probe being capable of hybridizing with two non-overlapping regions of said target sequence,

b) washing said solid support in order to remove material not bound to said support by hybridization, and

c) determining whether said marker is bound to said support, the presence of said marker indicating the presence of said single-stranded polynucleotide sequence in said sample.

6. The procedure according to claim 1 wherein said support is a tube, ball, particle, pipetting cone, or microtitration plate.

8. The procedure according to claim 1 wherein said target sequence is a messenger RNA sequence corresponding to a gene encoding beta-lactamase of E. coli (Tem) and wherein said capture probe is at least one of SEQ ID NO:

1 or SEQ ID NO;

8.

9. The procedure according to claim 8 wherein said detection probe contains at least one of SEQ ID NO:

17 or SEQ ID NO;

18.

10. The procedure according to claim 1 wherein said target sequence is a DNA sequence containing a gene encoding beta-lactamase of E. coli and wherein said capture probe is at least one of SEQ ID NO:

19 or SEQ ID NO;

20.

11. The procedure according to claim 10 wherein said detection probe contains at least one of SEQ ID NO:

21 or SEQ ID NO;

22.

12. The procedure according to claim 1 wherein said target sequence is a DNA sequence corresponding to the E7 gene of the human type 6 papilloma virus and wherein said capture probe is at least one of SEQ ID NO:

27 or SEQ ID NO;

28.

13. The procedure according to claim 12 wherein said detection probe contains at least one of SEQ ID NO:

29 or SEQ ID NO;

106.

14. The procedure according to claim 1 wherein said target sequence is a DNA sequence corresponding to the E7 gene of the human type 11 papilloma virus and wherein said capture probe is at least one of SEQ ID NO:

28 or SEQ ID NO;

33.

15. The procedure according to claim 14 wherein said detection probe contains at least one of SEQ ID NO:

29 or SEQ ID NO;

106.

16. The procedure according to claim 1 wherein said target sequence is a DNA sequence corresponding to an E7 gene of the human type 16 papilloma virus and said capture probe is SEQ ID NO:

41.

17. The procedure according to claim 16 wherein said detection probe contains at least one of SEQ ID NO:

43 or SEQ ID NO;

42.

18. The procedure according to claim 1 wherein said target sequence is a DNA sequence corresponding to the gag region of the HIV 1 retrovirus and said capture probe is SEQ ID NO:

58.

19. The procedure according to claim 18 wherein said detection probe contains SEQ ID NO:

59.

20. The procedure according to claim 1 wherein said target sequence corresponds to the gag region of the HIV 2 retrovirus and said capture probe is SEQ ID NO:

61.

21. The procedure according to claim 20 wherein said detection probe contains SEQ ID NO:

59.

22. The procedure according to claim 1 wherein said target sequence corresponds to the env region of the HIV 1 retrovirus and said capture probe is SEQ ID NO:

64.

23. The procedure according to claim 22 wherein said detection probe contains SEQ ID NO:

65.

2. Procedure for the detection of the presence or absence of a single base mutation in a single-stranded nucleotide target sequence, in a sample, comprising the steps of:

a) incubating said sample at a first temperature;

i) with a capture probe adsorbed to a hydrophobic solid support, wherein said capture probe is an oligonucleotide having from 11 to 19 nucleotides and said capture probe is not derivatized with a moiety to facilitate adsorption, and

ii) with a detection probe labelled with a non-radioactive marker,

said capture probe and said detection probe being substantially complementary to two non-overlapping regions of said target sequence, and said single base mutation, if present, being in the region of said target sequence which is substantially complementary to the sequence of said capture probe,

b) washing said solid support at a second temperature in order to remove material non-bound to said support by hybridization, and

c) determining whether said marker is bound to said support,

with the proviso that at least one of said first temperature and said second temperature is a temperature at which said capture probe will hybridize to only a completely complementary sequence in said target sequence, if present, and with the proviso that said capture probe is either

i) completely complementary to said target sequence containing said single base mutation or

ii) completely complementary to said target sequence not containing said single base mutation,

whereby the absence of said marker in proviso i) or the presence of said marker in proviso ii) indicates the absence of said single base mutation in said target sequence, and

whereby the presence of said marker in proviso i) or the absence of said marker in proviso ii) indicates the presence of said single base mutation in said target sequence.

3. The procedure according to claim 2 wherein at least one of said first temperature and said second temperature is in the range of 20°

C. to 60°

C.

4. The procedure according to claim 3 wherein at least one of said first temperature and said second temperature is in the range of 25°

C. to 40°

C.

5. The procedure according to claim 4 wherein at least one of said first temperature and said second temperature is 37°

C.

7. The procedure according to claim 2 wherein said support is a tube, ball, particle, pipetting cone, or microtitration plate.